Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
Pneumonia IV: Management01:28

Pneumonia IV: Management

299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Spatial transcriptomics uncovers vasculature-centered cellular interactions driving Japanese encephalitis progression in a mouse model.

Nature communications·2026
Same author

PVC microplastics facilitate uropathogenic Escherichia coli pathogenicity by enhancing host cell invasion and mitochondrial-dependent pyroptosis.

Nature communications·2026
Same author

LRP8 is a functional receptor for yellow fever virus.

Nature microbiology·2026
Same author

Spatial transcriptomics uncovers vasculature-centered cellular interactions driving Japanese encephalitis progression in a mouse model.

Nature communications·2026
Same author

Nondestructive tracking of viral infections by viral protein-initiated fluorescent sensors.

Journal of virology·2026
Same author

A metabolic alarmin from keratinocytes potentiates systemic humoral immunity.

Nature·2026

Related Experiment Video

Updated: Jun 6, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K

Inhalable nanocatalytic therapeutics for viral pneumonia.

Wenchang Peng1,2, Wanbo Tai3,4, Bowen Li1

  • 1Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.

Nature Materials
|November 26, 2024
PubMed
Summary

A novel inhalable nanozyme platform effectively reduces reactive oxygen species and inflammation in pneumonia models. This cerium-based nanozyme shows promise for treating viral pneumonia and secondary bacterial infections.

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

10.7K

Related Experiment Videos

Last Updated: Jun 6, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

10.7K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Respiratory Medicine

Background:

  • Pneumonia involves high reactive oxygen species (ROS) levels, complicating treatment.
  • Current therapies for pneumonia face challenges due to lung tissue complexity and inflammation.

Purpose of the Study:

  • To develop and evaluate an inhalable nanozyme platform for treating pneumonia.
  • To assess the efficacy of cerium-based tannic acid nanozymes in reducing oxidative stress and inflammation.

Main Methods:

  • Engineered cerium-based tannic acid nanozymes bound to self-assembling peptides.
  • In vitro and in vivo studies using a mouse model of viral pneumonia.
  • Evaluation of nanozyme internalization, ROS scavenging, cytokine reduction, and macrophage polarization.

Main Results:

  • Nanozymes were internalized by macrophages and epithelial cells at inflamed sites.
  • Nanozyme aggregates reduced ROS levels and inflammatory cytokine production in viral pneumonia.
  • The platform promoted prohealing (M2) macrophage polarization.
  • Nanozymes attenuated bacterial inflammation and reduced tissue damage in a co-infection model.

Conclusions:

  • The inhalable nanozyme platform is a promising non-invasive strategy for pneumonia treatment.
  • This approach effectively manages oxidative stress and inflammation associated with viral and secondary bacterial pneumonia.
  • The nanozyme platform demonstrates potential for treating pneumonia and related complications.